Oncology based Molecular Diagnostics Market Size Expected To Showcase At USD 3,391.0 Million By 2022 : Grand View Research Inc.
San Francisco, 26 September 2019: The Report Oncology based Molecular Diagnostics Market Analysis By Type (Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Kidney Cancer) By Product (Instruments, Reagents), By Test Location, By Technology (PCR, Multiplex PCR, In Situ Hybridization, Isothermal Nucleic Acid Amplification Technology (INAAT), Chips & Microarrays, Mass Spectrometry, Sequencing, Transcription Mediated Amplification) And Segment Forecasts To 2022 Global oncology based molecular diagnostics market is expected to reach USD 3,391.0 million by 2022 according to a new report by Grand View Research Inc. The rising geriatric population base, increasing global prevalence of cancer, rise in sedentary lifestyle adoption levels, and rising awareness & patient education are the driving forces for the oncology based molecular diagnostics market growth over the forecast period. Growing prevalence of cancer patie